Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Univ of North Carolina Chapel Hill
Chapel Hill, North Carolina
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 358
Name | Type | Company | Disclosed Value | Year Filed |
---|---|---|---|---|
Ian Davis | Conflict of Interest | Triangle Biotechnology, Inc. | $0 - $4,999 | 2018 |
Matthew Redinbo | Conflict of Interest | Symberix LLC | $0 - $4,999 | 2015 |
Flavio Frohlich | Conflict of Interest | Pulvinar Neuro | $0 - $4,999 | 2017 |
Karen Bluth | Conflict of Interest | Karen Bluth | $0 - $4,999 | 2016 |
Eric Bachelder | Conflict of Interest | Immvention Therapeutics | $0 - $4,999 | 2018 |
Kristy Ainslie | Conflict of Interest | Immvention Therapeutix | $0 - $4,999 | 2018 |
Christopher Sims | Conflict of Interest | Altis Biosystems, LLC | $0 - $4,999 | 2015 |
Kevin Weeks | Conflict of Interest | Ribometrix, Inc | $0 - $4,999 | 2017 |
John Sondek | Conflict of Interest | KXT Bio, Inc | $0 - $4,999 | 2018 |
Eric Bachelder | Conflict of Interest | Immvention Therapeutix | $0 - $4,999 | 2018 |
Aravind Asokan | Conflict of Interest | Stride Therapeutics | $0 - $4,999 | 2015 |
Paul Dayton | Conflict of Interest | Triangle Biotechnology, Inc. | $0 - $4,999 | 2018 |
Samantha Pattenden | Conflict of Interest | Triangle Biotechnology, Inc. | $0 - $4,999 | 2018 |
Eric Bachelder | Conflict of Interest | Immvention Therapeutix | $0 - $4,999 | 2018 |
Jenny Ting | Conflict of Interest | Immvention Therapeutics | $0 - $4,999 | 2018 |
Bruce Sullenger | Conflict of Interest | Tobira Therapeutics (formerly Regado Biosciences, Inc.) | 2015 | |
Robert Tarran | Conflict of Interest | Spyryx Biosciences, Inc. | 2016 | |
Richard Samulski | Conflict of Interest | Asklepios Biopharmaceutical Inc. | 2014 | |
Richard Samulski | Conflict of Interest | Asklepios Biopharmaceutical (askbio), Inc. | 2014 | |
Barbara Grubb | Conflict of Interest | Parion Sciences | 2014 | |
Otto Zhou | Conflict of Interest | Xintex, Inc | 2015 | |
Otto Zhou | Conflict of Interest | Xintex, Inc | 2015 | |
Lu Jianping | Conflict of Interest | Xintex, Inc | 2015 | |
Lu Jianping | Conflict of Interest | Xintex, Inc | 2015 | |
Nancy Allbritton | Conflict of Interest | Cell Microsystems, Inc | 2016 | |
Shelton Earp | Conflict of Interest | Meryx, Inc. | 2017 | |
J Ramsey | Conflict of Interest | Genturi, Inc. | 2018 | |
Gary Johnson | Conflict of Interest | Kinodyn | 2016 | |
Stephen Frye | Conflict of Interest | Meryx, Inc. | 2017 | |
Richard Samulski | Conflict of Interest | AskBio | 2016 | |
Matthew Redinbo | Conflict of Interest | Symberix LLC | 2015 | |
Aravind Asokan | Conflict of Interest | Stride Therapeutics | 2015 | |
Leaf Huang | Conflict of Interest | Qualiber, Inc. | 2015 | |
Aravind Asokan | Conflict of Interest | Stride Therapeutics | 2015 | |
Stephen Frye | Conflict of Interest | Meryx, Inc. | 2016 | |
Mark Schoenfisch | Conflict of Interest | Novan, Inc. | 2015 | |
Kevin Weeks | Conflict of Interest | Ribometrix | 2016 | |
Richard Samulski | Conflict of Interest | AskBio | 2016 | |
Paul Dayton | Conflict of Interest | Nanosonic Bioreagents | 2016 | |
Jenny Ting | Conflict of Interest | Immvention, Inc. | 2016 | |
John Sondek | Conflict of Interest | KXT Bio, Inc | 2018 | |
Alexander Kabanov | Conflict of Interest | Neuronano Pharma Inc. | 2015 | |
Joseph Desimone | Conflict of Interest | Liquidia Technologies | 2015 | |
Shawn Hingtgen | Conflict of Interest | Falcon Therapeutics | 2016 | |
Paul Dayton | Conflict of Interest | SonoVol, LLC | 2015 | |
Norman Sharpless | Conflict of Interest | Healthspan Dx | 2016 | |
Kristy Ainslie | Conflict of Interest | Immvention Therapeutix | 2019 | |
Eric Bachelder | Conflict of Interest | Immvention Therapeutics | 2017 | |
Kristy Ainslie | Conflict of Interest | Immvention Therapeutics | 2017 | |
Xiaodong Wang | Conflict of Interest | Meryx, Inc. | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.